Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jiangzhi Tongluo soft capsules for primary hyperlipidemia
ChiCTR1800014435Phase 4Completed
- Sponsor
- Second Affiliated Hospital of Heilongjiang University of Chinese Medicine
- Start
- Feb 2016
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Jiangzhi Tongluo in familial hyperlipidemia (2 arms), sponsored by Second Affiliated Hospital of Heilongjiang University of Chinese Medicine. Primary endpoint: Low-density lipoprotein. Started Feb 2016; status: completed.
02
Drugs
Jiangzhi Tongluo
03
Conditions
familial hyperlipidemia
Beyond the preview
Go deeper on ChiCTR1800014435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014435.